Ripretinib as a second-line therapy for advanced gastrointestinal stromal tumors in the era of precision medicine
@article{ACTR9420,
author = {Toshirou Nishida and Osakuni Morimoto and Yoshihito Ide},
title = {Ripretinib as a second-line therapy for advanced gastrointestinal stromal tumors in the era of precision medicine},
journal = {AME Clinical Trials Review},
volume = {2},
number = {0},
year = {2024},
keywords = {},
abstract = {},
issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/9420}
}